Purpose Iran lacks a national registry reporting the data of central nervous system (CNS) tumors in children. Consequently, treatment success and failure rates are unknown, and a centralized system for disease-management recommendations does not exist. Methods To critically evaluate the current state of pediatric CNS tumor studies and reporting in Iran, we performed an extensive retrospective analysis of all known reports identified with multiple search engines. Results Of 409 initially retrieved articles, we evaluated 123 matching our inclusion criteria. We further narrowed these reports to 74 by excluding studies pertaining to adult patients only, non-CNS tumors, or brain metastases. We also excluded studies that were performed outside of Iran or that did not contain relevant data from our analysis. We divided the remaining studies into those describing exclusively pediatric patients (3484 patients) and those describing mixed populations of adults and children (18,641 patients). In total, our analysis included 22,125 patients. Conclusions We identified many limitations in the reporting of studies describing the treatment or prevalence of CNS tumors in children in Iran. Our results may guide future efforts in Iran to improve the care for children with CNS tumors and may provide a valuable template for other comprehensive country-and disease-specific retrospective analyses.
Introduction
The prevalence of central nervous system (CNS) tumors is estimated to be lower in Iran (especially in Iranian women) than in western countries [1] . However, it is unclear whether this difference is the result of a lower level of reporting due to a reduced availability of health care services. Most reports of brain tumor studies in Iran describe results from single centerbased clinical trials and, therefore, do not adequately address the difference in the overall prevalence of CNS tumors [2] [3] [4] [5] . In addition, specific population-based estimates and a national cancer registry reporting system for pediatric CNS tumors are lacking in Iran [6] .
The aim of our retrospective analysis was to comprehensively evaluate all studies regarding pediatric patients with CNS tumors in Iran. In doing so, we easily identified the limitations in the reporting of such studies. Because most developing countries, including Iran, do not have a central registry dedicated to the reporting of specific patient populations with CNS tumors, the novel and systematic approach we describe here may be useful for the guiding of future reports in Iran and other developing countries. We have compiled the results of our analysis in a single database that can also serve as a practical point of reference for the treatment of children with CNS tumors in Iran. This can be used as a template for reporting analyses from other countries that lack a central registry describing CNS tumor studies, potentially improving the quality of reporting and clinical research design in the developing world.
Materials and methods
We performed electronic searches of articles published in English or Persian from 1980 to April 2016 with the Scopus, Web of Science, PubMed, Google Advanced Web Search, and Google Scholar search engines. The following Medical Subject Heading terms were used: Bcentral nervous system tumors^OR Bbrain^OR Bspine^OR Bspinal^OR BCNSÂ ND Btumor^OR Btumors^OR Bneoplasm*^OR Bmedulloblastoma*^OR Bglioma*^OR Bastrocytoma*Ô R Bgerm cell^OR Bgerminoma*^OR Bembryonal brain tumors*^OR Bperipheral neuroectodermal*^OR BPNET*Ô R Batypical rhabdoid teratoid*^OR BATRT*^OR Bchoroid plexus tumors*^OR Bependymoma*^AND Bchild^OR Bchildren^OR Bchildhood^OR Bpediatric^OR Badolescent.Â sterisks on search terms allow investigators to specifically search terms that are the major topics of the article and are usually included in the title or statement of purpose. The search terms were combined (i.e., AND) with the word BIran^to limit the searches to studies conducted in Iran.
A screen of the initial search results based on the title and abstract of each research article was performed, limiting the results to studies of brain tumors in Iran. These articles were subsequently acquired as full-text documents; however, four reports were available only as abstracts. Full-text research articles and abstracts were then subjected to the following exclusion criteria: (i) studies pertaining to only adult patients (in Iran, adults are persons >15 years), (ii) studies describing CNS and non-CNS cancers, (iii) studies pertaining primarily to brain metastases, (iv) studies conducted by Iranian researchers outside Iran, (v) studies lacking specific patient age ranges, (vi) and studies lacking any relevant data. After applying the exclusion criteria, we divided the remaining articles into two categories: those describing pediatric studies (i.e., studies including patients exclusively ≤15 years) or those describing mixed-population studies (i.e., studies including both pediatric and adult populations). Because the Iranian health care system defines pediatric patients as children younger than 15 years [6] , we considered reports of studies that specifically described patients who were less than 15 years as pediatric articles. We extracted the following data, if available, from the research articles: patient age at diagnosis (range, median, or mean), patient sex, CNS tumor type, 5-year overall survival, 5-year event-free survival, patient outcome (alive, dead, or lost to follow-up), total number of patients enrolled, study design, study objective, status of ethics committee approval, province where the study was conducted, written language of the article, and other notable points or findings.
Results

Search results
Initial searches with specific Medical Subject Headings yielded 409 potential research articles for analysis. After screening article titles and abstracts for irrelevant studies, we subjected the remaining 123 articles to further exclusion criteria (described in the BMaterials and methods^). On the basis of these criteria, we excluded 49 additional articles. We categorized the remaining 74 articles as those reporting pediatric studies (n = 35 articles, Table 1 ) or mixed-population studies (n = 39 articles, Table 2 ).
Reports of pediatric studies
From 35 articles published from 1980 to 2015, we analyzed the characteristics and outcomes of 3484 pediatric patients in Iran with CNS tumors (Table 1) [2] [3] [4] . The majority (57.7%) of the patients studied were boys. Approximately 84% of the patients in our analysis were described in 13 articles [2] [3] [4] [5] [7] [8] [9] [10] [11] [12] [13] [14] [15] that were published from 1980 to 2008. Two articles were written in Persian [8, 12] , whereas the remaining 33 were written in English. Most studies (n = 27) took place in Tehran province [4, 5, 8, 11-13, 15-23, 25-29, 31-37] in hospitals and centers affiliated with the three main medical universities in Tehran: Tehran University of Medical Sciences (n = 16) [4, 5, 11, 13, 16, 17, 19-22, 26, 28, 29, 31, 32, 37] , Shahid Beheshti University of Medical Sciences (n = 6) [12, 15, 18, 25, 27, 34] , Iran University of Medical Sciences (n = 4) [8, 23, 35, 36] , and Army University of Medical Science (n = 1) [33] . Only four articles [18, 23, 26, 34] stated that approval by an ethics committee had been obtained.
The study objectives were categorized as clinical (n = 18 articles, 173 patients), epidemiologic (n = 9 articles [5, 8, 12, 13, 16, 26, 28, 33, 34] , 1881 patients), pathologic (n = 4 articles [11, 14, 15, 18] , 1160 patients), genetic (n = 2 articles [7, 30] , 75 patients), surgical (n = 1 article [21] , 172 patients), or radiologic (n = 1 article [29] , 23 patients). Study designs were primarily single case reports (n = 16 articles [2-4, 9, 16, 17, 19-22, 24, 29, 31, 32, 36, 37] , 19 patients) and cross-sectional studies (n = 15 articles [7, 8, 10-15, 18, 25, 26, 28, 30, 33, 34] , 3271 patients). Other study designs included cohort (n = 2 articles [23, 35] , 131 patients), case series (n = 1 article [5] , 7 patients), and case control (n = 1 article [27] , 56 patients) ( Table 1) .
Of the 18 articles categorized as clinical, 13 were case reports (19 patients) [2-4, 9, 17, 19, 20, 22, 24, 31, 32, 36, 37] , two were cross-sectional studies (98 patients), two were cohort studies (98 patients), and one was a case-control study (56 patients). Clinical case reports described the disease presentation and management for each patient. Of the 35 total Prediagnostic symptom interval data was included in the report AAST anaplastic astrocytoma, Male and female patient data was not available. Number represents total patient population in study pediatric study articles, six (published from 2006 to 2014) described the prediagnostic symptomatic interval (PSI) in children with CNS tumors [2, 5, 12, 19, 24, 33] . The followup of patients, 5-year overall survival, and event-free survival rates were reported in nine articles [8, 23, 25-28, 30, 33, 35] .
Reports of mixed-population studies
From 1997 to 2016, 39 published articles described the treatment and characteristics of 18,642 pediatric and adult patients in Iran with CNS tumors (Table 2 ) . One article was written in Persian [69] , and the remaining articles were written in English. Eight reports described whether approval from an ethics committee was obtained [59, 60, [52-54, 64, 72] . The study objectives were categorized as genetic (n = 9 articles [38, 44, 50, 56, 62, 65, 66, 70, 71] , 449 patients), epidemiologic (n = 7 articles [47, 49, 60, 61, 63, 69, 74] , 13,193 patients), pathologic (n = 7 articles [46, 48, 52, 55, 67, 68, 72] , 4365 patients), clinical (n = 6 articles [39, 41, 43, 45, 57, 76] , 393 patients), radiologic (n = 4 articles [, 86 patients), radiotherapy (n = 3 articles [54, 58, 59, 73] , 54 patients), surgical (n = 2 articles [42, 51] , 44 patients), or virologic [75] (n = 1, 58 patients).
The most prevalent study design was cross sectional (n = 25 articles, 5323 patients). Three studies were case series (47 patients) [39, 44, 54] , two were case reports (7 patients) [40, 76] , two were cohorts (12,750 patients) [60, 61] , two were case controls (150 patients) [69, 70] , and two were descriptive (178 patients) [50, 55] . One study was retrospective (141 patients) [43] , and two articles [59, 66] did not report the type of study design (46 patients). The single retrospective study reviewed the clinical presentation, radiographic evaluation, treatment, and follow-up of 141 patients with craniopharyngiomas. PSI was evaluated in only one study [41] , which was reported in 2004. Seven articles described the follow-up of patients [41, 51, 53, 57, 64, 65, 75] .
Reports of excluded studies
Forty-nine articles were excluded from the study. The excluded articles included 34 that pertained only to adult patients and were categorized as clinical (n = 16), epidemiologic (n = 5), genetic (n = 5), surgical (n = 4), radiologic (n = 3), or pathologic (n = 1). Six studies were conducted by Iranian researchers outside of Iran. The study objectives in those articles were clinical (n = 3), epidemiologic (n = 1), or surgical (n = 1), and one article was a letter to the editor. We excluded four articles, because the age of enrolled patients was not reported. These articles were categorized as epidemiologic (n = 1), clinical (n = 1), or genetic (n = 2). We excluded two epidemiologic articles, because they reported studies of CNS and non-CNS tumors. We excluded two articles that were clinical and epidemiologic, because they reported studies of only brain metastases. Finally, we excluded one clinical article because it did not report any data.
Discussion
Our analysis of the data extracted from the pediatric studies revealed some limitations in these reports. A large majority (77%) of the pediatric studies were conducted in Tehran province. The remaining eight studies were conducted in eight other provinces [2, 3, 7, 9, 10, 14, 24, 30] . Because the city of Tehran contains three major pediatric cancer referral centers and pediatric patients in Iran are frequently referred to these centers, it is not surprising that most of the studies were conducted there. Four articles did not report the median or mean age of the patients in their studies [7, 10, 12, 14] . The study objectives of those four studies were genetic, pathologic, or epidemiologic. Of the 20 pediatric studies with clinical study objectives, 16 (80%) presented unique cases, three described patient survival rates, and one evaluated the PSIs of the patients. All case reports focused on disease presentation. From our analysis of these studies, it is apparent that adequate reporting of treatment protocols used for CNS tumor therapy in children is lacking in Iran.
Only two articles described pediatric studies with a genetic objective. The lack of genetic studies of pediatric patients in Iran is most likely due to a limited number of facilities employing genetic researches and an inability of pediatric oncologists to conduct genetic studies. Iranian pediatric hematologists-oncologists are more likely to present case reports (fostering consultations) and design epidemiologic studies. A lack of collaboration among referral centers most likely contributed to the limited number of cohort and crosssectional studies. In addition, very few studies (17%) measured survival or followed up their pediatric patients with CNS tumors. Only four articles reported approval of their study by an ethics committee, although all studies in Iran with human subjects are required to obtain approval from an institutional review board or equivalent ethics committee. It is difficult to discern whether this discrepancy is due to a lack of reporting by the authors or a lack of ethics committee approval.
Unlike the pediatric studies in our analysis, the mixedpopulation studies were conducted in many additional provinces throughout Iran. Although a majority of these studies were conducted in Tehran province (54%), many were conducted in Isfahan (18%) and Fars (15%) provinces. In addition, five studies were conducted in five other provinces [47, 76] . Our findings demonstrate that studies with mixed populations of adults and children are less likely to be conducted at the three major cancer referral centers located in Tehran.
The most frequently reported study objectives in the mixed-population studies were genetic, epidemiologic, pathologic, and clinical. Other study objectives were radiologic, radiotherapy, surgical, and virologic. The most commonly reported type of study design was cross sectional. Six crosssectional studies evaluated the survival and follow-up of patients, and only one determined the PSIs of patients [41] . Of the 38 reports of mixed-population studies, eight indicated whether ethics committee approval was obtained. One report of a cross-sectional pathologic study stated that ethics committee approval was not required [72] .
In conclusion, our analysis of the reporting of CNS tumors in pediatric patients in Iran revealed many limitations. The most frequently published articles are case reports, and articles that report data obtained from the treatment, outcome, and follow-up of patients are rare. Nevertheless, identification of the limitations of the reporting of diseasespecific clinical studies in Iran may provide insight for future research studies and their publication. In addition, our comprehensive analysis may provide a valuable guideline for future initiatives in Iran or other developing countries, encouraging investigators to avoid the limitations we have described. To our knowledge, this study is the first systematic analysis of every report describing pediatric brain tumor studies from a single developing country. The strategy that we have employed will be useful for future analyses of the reporting efficiencies and limitations in other developing countries, especially those that do not have a central registry describing CNS tumor studies.
